3-((3-cholamidopropyl)dimethylammonium)-1-propanesulfonate has been researched along with butaclamol in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jenner, P; Kilpatrick, GJ; Marsden, CD | 1 |
1 other study(ies) available for 3-((3-cholamidopropyl)dimethylammonium)-1-propanesulfonate and butaclamol
| Article | Year |
|---|---|
[125I]Spiperone is not a useful ligand for studying the CHAPS solubilized dopamine D-2 receptor from rat striatum.
Topics: Animals; Butaclamol; Butyrophenones; Cholic Acids; Corpus Striatum; Female; In Vitro Techniques; Kinetics; Ligands; Rats; Rats, Inbred Strains; Receptors, Dopamine; Spiperone | 1986 |